APC
MRK icon

Aspire Private Capital’s Merck MRK Stock Holding History

Aspire Private Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$362K Sell
2,819
-658
-19% -$77K 0.07% 135
2026
Q1 		$418K Buy
3,477
+536
+18% +$61.9K 0.09% 130
2025
Q4 		$310K Sell
2,941
-36
-1% -$3.38K 0.07% 139
2025
Q3 		$250K Sell
2,977
-1,085
-27% -$89.4K 0.05% 163
2025
Q2 		$322K Sell
4,062
-837
-17% -$66.5K 0.07% 153
2025
Q1 		$440K Sell
4,899
-8,097
-62% -$756K 0.11% 134
2024
Q4 		$1.29M Buy
12,996
+1
+0% +$103 0.32% 60
2024
Q3 		$1.48M Buy
12,995
+962
+8% +$114K 0.35% 54
2024
Q2 		$1.49M Buy
12,033
+833
+7% +$107K 0.38% 48
2024
Q1 		$1.48M Buy
11,200
+1,321
+13% +$163K 0.39% 43
2023
Q4 		$1.08M Buy
9,879
+302
+3% +$31.3K 0.32% 45
2023
Q3 		$986K Buy
9,577
+379
+4% +$40.9K 0.32% 40
2023
Q2 		$1.06M Sell
9,198
-810
-8% -$92K 0.34% 42
2023
Q1 		$1.06M Sell
10,008
-44
-0.4% -$4.75K 0.35% 42
2022
Q4 		$1.12M Buy
10,052
+545
+6% +$55.7K 0.4% 39
2022
Q3 		$819K Sell
9,507
-143
-1% -$12.8K 0.31% 44
2022
Q2 		$880K Sell
9,650
-804
-8% -$71.3K 0.31% 43
2022
Q1 		$858K Buy
10,454
+2,216
+27% +$175K 0.27% 44
2021
Q4 		$631K Buy
8,238
+6,045
+276% +$481K 0.2% 71
2021
Q3 		$165K Buy
2,193
+73
+3% +$5.55K 0.06% 145
2021
Q2 		$165K Sell
2,120
-1,726
-45% -$128K 0.05% 150
2021
Q1 		$283K Sell
3,846
-3,898
-50% -$288K 0.1% 121
2020
Q4 		$604K Buy
7,744
+1,693
+28% +$129K 0.23% 66
2020
Q3 		$479K Buy
6,051
+959
+19% +$75.1K 0.2% 72
2020
Q2 		$379K Buy
5,092
+1,458
+40% +$110K 0.18% 75
2020
Q1 		$267K Buy
3,634
+1,704
+88% +$134K 0.14% 78
2019
Q4 		$168K Buy
1,930
+29
+2% +$2.38K 0.07% 121
2019
Q3 		$153K Buy
1,901
+117
+7% +$9.38K 0.07% 119
2019
Q2 		$143K Buy
1,784
+178
+11% +$13.6K 0.07% 129
2019
Q1 		$127K Buy
1,606
+849
+112% +$63.5K 0.06% 153
2018
Q4 		$55K Buy
+757
New +$53.4K 0.03% 207

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Aspire Private Capital's MRK Position: Q2 2026 in Review

Aspire Private Capital reduced its Merck (MRK) stake by 19% in Q2 2026, selling an estimated $77K and leaving 2,819 shares worth $362K. The position accounts for 0.07% of the portfolio, ranked #135.

Aspire Private Capital first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.49M in Q2 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aspire Private Capital held 2,819 shares of Merck worth $362K as of Q2 2026.
  • Aspire Private Capital sold 658 Merck shares in Q2 2026, an estimated $77K.
  • Merck made up 0.07% of Aspire Private Capital's portfolio in Q2 2026, its #135 holding.
  • Aspire Private Capital first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
  • Aspire Private Capital's Merck position peaked at $1.49M in Q2 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aspire Private Capital's 13F filing for Q2 2026, filed 15 Jul 2026.